Three patents currently held, every record listed here
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jan 2030. from the record
Of the 2 now held by other companies, 1 name Oncotherapy Science Inc. as their current owner, and 1 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
2
Ending by 2030
Jan 2030
Next term end
3
Patent families
When these terms end
Each bar runs from grant to computed term end. 2011 to 2034.
US 8,053,556
GLYPICAN-3 (GPC3)-Derived Tumor Rejection Antigenic Peptides Useful for HLA-A2-POSITIVE Patients and Pharmaceutical Comprising the Same
May 2, 2027
US 8,404,992
Method of Welding Metallic Glass with Crystalline Metal by High-Energy Beam
Jan 5, 2030
US 9,713,805
Exhaust Gas Purification Catalyst and Exhaust Gas Purification Catalyst Structure
Nov 10, 2034
20162021202620312034
5 pending applications: term is not computable until grant.Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Feb 2034 · High confidence
Also notable
Ends Jan 2030 · High confidence
Also notable
Ends Jun 2030 · High confidence
Acoustic Signal Processing Device and Method
US 9,190,047
The most cited patent in this portfolio, cited by 30 later US patents, top 25% of utility patents granted in 2015 in our data. Protection runs to 2034.
Method of Welding Metallic Glass with Crystalline Metal by High-Energy Beam
US 8,404,992
Renewed at every maintenance window since the 2013 grant; no more fees are due before its term ends in 2030.
Monoclonal Antibodies That Bind to the V3 Loop of HIV-1 GP120.
US 8,722,861
Renewed at every maintenance window since the 2014 grant; no more fees are due before its term ends in 2030.
Formerly held, still cited
Notable
Ends May 2027 · High confidence
Renewed at every maintenance window since the 2011 grant; no more fees are due before its term ends in 2027.
now held by Oncotherapy Science, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 17, 2027The maintenance fee for Acoustic Signal Processing Device and Method (US 9,190,047) comes due May 17, 2027. Unpaid by Nov 17, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 2 largest of its 3 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Monoclonal Antibodies That Bind to the V3 Loop of HIV-1 GP120. | 1 in force | to Jun 2030 |
| Method of Welding Metallic Glass with Crystalline Metal by High-Energy Beam | 1 in force | to Jan 2030 |
Patents held now
Soonest term end first.
Showing 1 to 3 of 3
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,404,992 | Method of Welding Metallic Glass with Crystalline Metal by High-Energy Beam held by Kumamoto University and Kuroki Kogyosho Co., Ltd. In force · High confidence | In force | High confidence | |
| US 8,722,861 | Monoclonal Antibodies That Bind to the V3 Loop of HIV-1 GP120. In force · High confidence | In force | High confidence | |
| US 9,190,047 | Acoustic Signal Processing Device and Method held by Honda Motor Co., Ltd. and Kumamoto University In force · High confidence | In force | High confidence |
Also on record, not counted in the 3: 2 patents in force now held by others · 9 patents ended · 5 applications pending · 12 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.